1351813-70-1 Usage
Description
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is a heterocyclic chemical compound with the molecular formula C7H3BrClN3. It features a pyrazolo[4,3-b]pyridine backbone and has bromine and chlorine substituents on the 7th and 5th carbon atoms, respectively.
Uses
Used in Pharmaceutical Industry:
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is used as a potential candidate in the development of new drugs and agrochemicals due to its unique chemical structure and reactivity.
Used in Research:
7-bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine is used as a building block for the synthesis of other heterocyclic compounds, contributing to the advancement of chemical research and the creation of novel compounds with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1351813-70-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,1,8,1 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1351813-70:
(9*1)+(8*3)+(7*5)+(6*1)+(5*8)+(4*1)+(3*3)+(2*7)+(1*0)=141
141 % 10 = 1
So 1351813-70-1 is a valid CAS Registry Number.
1351813-70-1Relevant articles and documents
MACROCYCLES AS PDE1 INHIBITORS
-
, (2019/06/30)
The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
, (2019/07/10)
The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
, (2018/09/25)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
